October 12, 2015 Social Clips by Isaura Santos Listen to MS News Today’s Exclusive Interview With Roche on Ocrelizumab Dr. Peter Chin, a renowned neurologist and Principal Medical Director of Global Neuroscience Development at Genentech, a member of the Roche Group, participated in an exclusive interview with Multiple Sclerosis News Today correspondent Dr. Ana de Barros on the company’s promising multiple sclerosis (MS) therapy ocrelizumab. Read the article: https://bit.ly/1JZddMJ…
July 8, 2015 News by Isaura Santos 1200 People With Relapsing MS Needed For RPC1063, Avonex Clinical Trials Clinical investigators worldwide are beginning to recruit 1,200 patients with relapsing multiple sclerosis for a study assessing the effectiveness of two different doses of RPC1063 (Receptos, Inc.), an experimental oral therapy, and Avonex® (interferon beta-1a, Biogen Inc.) in order to reduce relapse rate in patients. This study, called the Sunbeam Study, is being funded by…
July 7, 2015 News by Isaura Santos Report Shows MS Patients Miss Out On Access To Palliative Care Services A recent report by Marie Curie fellows organization suggests that those suffering from neurological conditions such as multiple sclerosis are missing out on care that could make a major difference in the quality of their lives. When it comes to palliative care, the report contends that there is a limited understanding about the need…
June 24, 2015 News by Isaura Santos Association Of British Neurologists Releases New Guidelines For Multiple Sclerosis The Association of British Neurologists (ABN) recently published new guidelines for how Disease Modifying Therapies (DMTs) for relapsing remitting multiple sclerosis should be monitored and prescribed in the United Kingdom, emphasizing the “right treatment at the right time.” There are currently ten DMTs available on the National Health System (NHS) and eleven in…
April 8, 2015 News by Isaura Santos Multiple Sclerosis Patients Could One Day Benefit From Brain Boost Study A recent study suggests that in the future multiple sclerosis patients could benefit from treatments intended to boost their brain function. The study was published in Nature Neuroscience and received funding from The Wellcome Trust, the Lister Research Prize and the Biotechnology and Biological Sciences Research Council. According to researchers, patients…
February 24, 2015 News by Isaura Santos Pathological Progression of Multiple Sclerosis Documented For The First Time An international group of researchers from the Center for Brain Research at the MedUni Vienna have published a paper in the Lancet Neurology journal titled “Pathological mechanisms in progressive multiple sclerosis,” documenting the pathological progress of MS since its early stages to what is known about…
December 11, 2014 News by Isaura Santos MS Society Heralds 2014 as a Year Of Great Progress in Multiple Sclerosis Research 2014 was a year of major progress in research for treating and curing multiple sclerosis (MS), according to the National Multiple Sclerosis Society. This year the National Multiple Sclerosis Society reports that the organization invested over $50 million into 380 new and ongoing research initiatives and projects for MS. The Society remains highly…
December 8, 2014 News by Isaura Santos Disappointing Results for Fingolimod Phase III Trial In Primary Progressive MS Novartis International recently provided an update on its fingolimod Phase III trial evaluating the use of the drug in primary progressive multiple sclerosis (PPMS), reporting that the study did not reveal any significant benefits of prescribing fingolimod over a placebo. However, results regarding…
December 8, 2014 News by Isaura Santos Ipsen Biopharmaceuticals Announces FDA To Review sBLA For Dysport® As Treatment For Upper Limb Spasticity Ipsen Biopharmaceuticals, Inc announced that the United States Food and Drug Administration (FDA) has agreed to review the supplemental Biologics License Application (sBLA) for Dysport® (abobotulinumtoxinA) to treat upper limb spasticity, a condition that affects many people in the United States, including multiple sclerosis (MS)…
November 19, 2014 News by Isaura Santos ‘Treat Me Right’ MS Society Campaign Shortlisted For Award The Treat Me Right campaign from the MS Society in the UK was recently shortlisted for this year’s voluntary sector campaign Public Affairs Award. The campaign was launched in April 2014 during MS Week to raise awareness for the importance of providing the right treatment at the right moment…
November 14, 2014 News by Isaura Santos Will It Be Possible To Predict Good And Bad Days For Multiple Sclerosis Patients? Highmark Blue Cross Blue Shield is trying to assess the possibility of predicting good and bad days for people suffering with multiple sclerosis (MS) and help them to achieve a higher quality of life. The four-week pilot program enrolled almost 100 participants that wore a body sensor patch,…
October 30, 2014 News by Isaura Santos Multiple Sclerosis, Autoimmune Disease Diagnoses, Treatments To Improve Using New DNA Software Researchers from UC San Francisco, the Broad Institute of MIT and Harvard, and Yale School of Medicine recently developed a software tool that helps researchers understand the complex genetic origins of many autoimmune diseases and, ultimately, to better diagnose and treat them. The study was published yesterday in …
October 17, 2014 News by Isaura Santos “MS Radio” Offers Multiple Sclerosis Patients Breaking News, Articles & Tips About the Disease Multiple Sclerosis information resource MSology.com has announced the launch of MS Radio, an exclusive MS-focused radio program, to celebrate the organization’s second anniversary. MSology.com provides news, feature articles and practical tips to more than 100,000 people worldwide. The first radio episode (available here) is…
October 14, 2014 News by Isaura Santos Multiple Sclerosis Patients Gain Access To Novel Image Sharing Platform StatRad is a technology leader in radiology and HealthCare Journey a virtual multiple sclerosis center and educator website guided by the motto, Stop Searching Start Learning. According to a recent press release, the two companies have teamed up to offer…